Breast cancer is considered as a killer disease and it is famous to be the top cause of cancer fatality among women. According to American cancer society, an estimated 1.3 million new breast cancer cases are identified each year which consists of 465,000 deaths. In order to productively tackle this devastating disease, we should push revolutionary scientists to study cancer at its most basic stage. In other words, breast cancer investigation work must be done at its molecular level. Additionally, other than the governments, private organizations should offer flexible budget to scientists who will be conducting breast cancer research work.
Proper financial support of breast cancer investigation projects; can not only lead to improved prevention techniques but it can also help towards earlier detection techniques and new anticancer medication and treatments.
Recently, researchers who are researching towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is possibly to treat women with treatment - resistant HER2 - positive breast cancer and therefore be able to prevent cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to avoid early development of such tumours. Now therapies such as trastuzumab and lapatimib are used towards treating breast cancer patients. However, it was recently observed that a huge group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a specifically destructive kind of tumour that affects an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is created by the body's own cells. It offers a cancer combating gene into cells, which subsequently produce immune system proteins and also cancer ? destroying cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by utilizing so - called naked DNA from genes that produces the HER2 receptor. This DNA is combined with an immune stimulant. The process involved in the creation of the vaccine, is named as electro oration.
In this method, pulses of electricity were utilized in order to inject the vaccine into the leg muscles in rats. The genes moved towards the cells, which then produced HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells. - 30427
Proper financial support of breast cancer investigation projects; can not only lead to improved prevention techniques but it can also help towards earlier detection techniques and new anticancer medication and treatments.
Recently, researchers who are researching towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is possibly to treat women with treatment - resistant HER2 - positive breast cancer and therefore be able to prevent cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to avoid early development of such tumours. Now therapies such as trastuzumab and lapatimib are used towards treating breast cancer patients. However, it was recently observed that a huge group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a specifically destructive kind of tumour that affects an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is created by the body's own cells. It offers a cancer combating gene into cells, which subsequently produce immune system proteins and also cancer ? destroying cells.
According to the primary researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by utilizing so - called naked DNA from genes that produces the HER2 receptor. This DNA is combined with an immune stimulant. The process involved in the creation of the vaccine, is named as electro oration.
In this method, pulses of electricity were utilized in order to inject the vaccine into the leg muscles in rats. The genes moved towards the cells, which then produced HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells. - 30427
About the Author:
Jason Myers is a professional writer and he writes mostly about cancer cure research news. He's also interested in writing cancer information online.
